Introduction.-Galactose-i-phosphate-uridyl transferase (transferase) catalyzes a reversible hexose exchange which results in the formation of uridine diphosphate galactose (UDPGal) and glucose-1-phosphate (Glu-1-P) from galactose-1-phosphate (Gal-1-P) and uridine diphosphate glucose (UDPGlu):
Gal-1-P + UDPGlu =;UDPGal + Glu-1-P. This enzyme is absent or deficient in the erythrocytes of galactosemicsl thus partially blocking the normal metabolism of galactose. As much of the ingested galactose is not excreted by galactosemics,2'3 the possibility of an incomplete metabolic block or of an alternative pathway of galactose metabolism must be considered. Such an alternative pathway has been demonstrated in liver. 4 Methods have been devised to detect galactosemics, based upon measuring (1) galactose tolerance, (2) the Gall-P which accumulates in the red cells,6 or (3) the transferase level in the red cells. The description and application of the modified transferase assay are the subject of this communication.
Methods.-The initial assay for transferase was based on the original procedure of Kalckar et al.' and consisted of incubating hemolyzates of red cells with Gal-1-P and UDPGlu. The residual UDPGlu was determined spectrophotometrically by relating the quantitative reduction of diphosphopyridine nucleotide (DPN) to UDPGlu in the dehydrogenase catalyzed oxidation of UDPGlu to UDPGlucuronic acid. The UDPGal formed was determined by the addition of a purified UDPGal-4-epimerase to the same reaction mixture after the dehydrogenase catalyzed reaction had ceased. This assay resulted in the qualitative detection of the transferase, but was not suitable for further studies requiring more quantitative enzyme levels.
The modified assay, as now employed, is similar to the most recent enzymatic assays published by Anderson et al. 7 and Maxwell et al.'0 with the following principal exceptions: the present procedure employs a higher concentration of UDPGlu and a higher ratio of Gal-1-P to UDPGlu, less hemolyzate, and a shorter incubation period. A fourfold excess of Gal-i-P over that of UDPGlu was necessary for optimum transferase activity. While using these assay conditions, namely, 0.20 MM UDPGlu and 0.80 AM Gal-1-P, the amount of hemolyzate (equal volume of water and red cells) was varied in a 15-min incubation period to determine the optimum enzyme concentration. In similar experiments, the substrate concentration and the incubation time were varied while the amount of hemolyzate was held constant at 0.2 ml (Fig. 1 was then added to the control cell and reset to a zero absorption before a similar addition to each assay cell. After the increase in optical density had ceased, 0.01 ml of UDPGal4-epimerase was added to each cell in the same manner as described for the dehydrogenase and any further reduction of DPN was noted. The difference in optical density increases before the addition of the epimerase was calculated as UDPGlu consumed in the transferase catalyzed reaction. The increase in optical density after addition of epimerase was calculated as UDPGal formed in the same reaction. The UDPGal recovered was 85 to 105 per cent of the UDPGlu consumed.
Results and Discussion.-In the application of the method, the levels of the transferase in red cells of galactosemics, their families, and normal individuals were determined. Results for three typical families and appropriate controls are shown (Table 1) . A more detailed genetic study involving several more families will be published elsewhere. Enzyme levels are expressed as ,4M UDPGlu consumed per hour of incubation both per milliliter of red cells and per gram of hemoglobin. Before positive identification of the subjects, the values were categorized as follows: 0, galactosemics; 2.9-3.7, parents or carriers; 4.8-8.1, normal. Subsequent work with a greater population will define the expected range of transferase levels for patients, carriers, and normals more precisely.
Anderson et al.7 reported normal transferase levels in the range of 2.4-3.5 JAM of UDPGlu utilized per gram of hemoglobin per hour. The levels reported by Hsia et al.9 are also in the same low category and consequently, when applied to a study of galactosemics and their families, there was marked overlapping in the various categories listed above, particularly in the carrier and normal groups. This is in part due to limitations of the assay employed since the high values were underestimated. The more quantitative procedure described herein yields values of greater magnitude, thus extending the over-all range with no overlapping between galactosemics, carriers, and normals. The carrier category is intermediate between the other two groups.
It has been suggested that galactosemia is inherited as a simple recessive characteristic.6 Data presented here substantiate this concept. The results of the application of an improved enzymatic method to a study of transferase levels indicate that it is possible to detect parents who are likely to give birth to galactosemics and to survey a larger population of galactosemic and normal individuals to determine more precisely the genetics and also the incidence of this metabolic disorder. As galactosemia and other metabolic diseases may in some cases limit mental development, a consideration of transferase levels in mentally retarded patients should reveal if a significant number of patients have an abnormal galactose metabolism. Such a study is presently in progress.
Conclusions.-Existing procedures have been modified to determine galactose-1-phosphate uridyl transferase quantitatively in human erythrocytes. This method has been applied to galactosemics, their families, and appropriate normal individuals Incubation conditions were as follows: 0.20 pM UDPGlu, 0.80 AM Gal-1-P, 0.10 ml glycine buffer (1 M, pH 8.7), and 0.20 ml hemolyzate (1: 1 ratio of red cells and water), made to final volume of 0.45 ml with water. Incubation time was 10 min at 37'C. The incubation mixture was denatured by placing in a boiling water bath for 2 min. After centrifugation, UDPGlu and UDPGal were determined as described in the text.
Results for three typical families are reported. As parents have a transferase level which is intermediate between the normal and the galactosemic, carriers of this genetic disorder may be detected by determination of transferase in the red cells. This procedure should be useful in a more detailed consideration of the genetics of this disorder.
